Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results on 49 cases from a multicentre study (Q70360949)
Jump to navigation
Jump to search
scientific article published on 01 January 1987
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results on 49 cases from a multicentre study |
scientific article published on 01 January 1987 |
Statements
Double-blind study of Anandron versus placebo in stage D2 prostate cancer patients receiving buserelin. Results on 49 cases from a multicentre study (English)